Los Angeles [US]: Hollywood actor Emma Stone won the Best Actress award at the Oscars 2024 for her performance in the film ‘Poor Things.’
Taking to X, The Academy shared a post and wrote, “And the Oscar for Best Actress goes to… Emma Stone!”
Emma won over Annette Bening (Nyad), Lily Gladstone (Killers of the Flower Moon), Sandra Huller (Anatomy of a Fall), Carey Mulligan (Maestro).
‘Poor Things’ also bagged the golden trophy for Best Production Design, Best Costume Design, and Best Makeup and Hairstyling categories at the 96th Academy Awards.
The Oscars 2024 held at the Dolby Theatre in Hollywood, Los Angeles.
Earlier Emma Stone won the Best Actor award for her performance in ‘Poor Things’ at the Golden Globe Awards 2024, Critics Choice Awards 2024, and BAFTA Awards 2024.
In the film, Emma Stone plays Bella, a Victorian-era woman who was brought back to life with the brain of a fetus; her performance was widely praised by critics, according to The New York Times.
Yorgos Lanthimos directed ‘Poor Things’, a 2023 scientific fantasy black comedy film written by Tony McNamara. It is based on Alasdair Gray’s novel from 1992. It stars Emma Stone, Mark Ruffalo, Willem Dafoe, Ramy Youssef, Christopher Abbott, and Jerrod Carmichael. The plot revolves around Bella Baxter, a young Victorian woman who, after being ruthlessly resurrected by a scientist following her suicide, flees with a debauched barrister on a journey of self-discovery and sexual liberation.
The stylish mid-size Tata Harrier SUV is famous for its striking design, good build quality,…
November 23, 2024: The Border-Gavaskar Trophy, renowned for its fierce competition and high stakes, witnessed…
November 23, 2024: Naga Chaitanya has had a busy year, both personally and professionally. On…
November 23, 2024: Yashasvi Jaiswal's remarkable achievement on Day 2 of the Border-Gavaskar Trophy (BGT)…
November 23, 2024: Yashasvi Jaiswal and KL Rahul's stunning 172-run opening partnership on Day 2…
November 23, 2024: India has firmly positioned itself in the driver's seat in the ongoing…